{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:41:43Z","timestamp":1761237703963},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,4,2]],"date-time":"2010-04-02T00:00:00Z","timestamp":1270166400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s10822-010-9347-3","type":"journal-article","created":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T13:15:09Z","timestamp":1270127709000},"page":"399-408","source":"Crossref","is-referenced-by-count":33,"title":["Site of metabolism prediction on cytochrome P450 2C9: a knowledge-based docking approach"],"prefix":"10.1007","volume":"24","author":[{"given":"\u00c1kos","family":"Tarcsay","sequence":"first","affiliation":[]},{"given":"R\u00f3bert","family":"Kiss","sequence":"additional","affiliation":[]},{"given":"Gy\u00f6rgy M.","family":"Keser\u0171","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,4,2]]},"reference":[{"key":"9347_CR1","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/nrd1032","volume":"2","author":"H Waterbeemd van de","year":"2003","unstructured":"van de Waterbeemd H, Gifford E (2003) ADMET in silico modelling: towards prediction paradise? Nat Rev Drug Discov 2:192\u2013204","journal-title":"Nat Rev Drug Discov"},{"key":"9347_CR2","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1021\/jm070745g","volume":"50","author":"MM Ahlstr\u00f6m","year":"2007","unstructured":"Ahlstr\u00f6m MM, Ridderstr\u00f6m M, Zamora I (2007) CYP2C9 structure-metabolism relationships: substrates, inhibitors, and metabolites. J Med Chem 50:5382\u20135391","journal-title":"J Med Chem"},{"key":"9347_CR3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1021\/jm8008663","volume":"52","author":"M Trunzer","year":"2009","unstructured":"Trunzer M, Faller B, Zimmerlin A (2009) Metabolic soft spot identification and compound optimization in early discovery phases using MetaSite and LC-MS\/MS validation. J Med Chem 52:329\u2013335","journal-title":"J Med Chem"},{"key":"9347_CR4","doi-asserted-by":"crossref","unstructured":"Vasanthanathan P, Hritz J, Taboureau O, Olsen L, J\u00f8rgensen FS, Vermeulen NP, Oostenbrink C Virtual screening and prediction of site of metabolism for cytochrome P450 1A2 ligands. J Chem Inf Model 49:43\u201352","DOI":"10.1021\/ci800371f"},{"key":"9347_CR5","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1126\/science.287.5458.1615","volume":"287","author":"I Schlichting","year":"2000","unstructured":"Schlichting I, Berendzen J, Chu K, Stock AM, Maves SA, Benson DE, Sweet RM, Ringe D, Petsko GA, Sligar SG (2000) The catalytic pathway of cytochrome p450cam at atomic resolution. Science 287:1615\u20131622","journal-title":"Science"},{"key":"9347_CR6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature01862","volume":"424","author":"PA Williams","year":"2003","unstructured":"Williams PA, Cosme J, Ward A, Angove HC, Matak Vinkovi\u0107 D, Jhoti H (2003) Crystal structure of human cytochrome P450 2C9 with bound warfarin. Nature 424:464\u2013468","journal-title":"Nature"},{"key":"9347_CR7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cbi.2008.09.013","volume":"179","author":"KS Pang","year":"2009","unstructured":"Pang KS (2009) Safety testing of metabolites: expectations and outcomes. Chem Biol Interact 179:45\u201359","journal-title":"Chem Biol Interact"},{"key":"9347_CR8","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1124\/dmd.104.000794","volume":"32","author":"JA Williams","year":"2004","unstructured":"Williams JA, Hyland R, Jones BC, Smith DA, Hurst S, Goosen TC, Peterkin V, Koup JR, Ball SE (2004) Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi\/AUC) ratios. Drug Metab Dispos 32:1201\u20131208","journal-title":"Drug Metab Dispos"},{"key":"9347_CR9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2125.1998.00721.x","volume":"45","author":"JO Miners","year":"1998","unstructured":"Miners JO, Birkett DJ (1998) Cytochrome P4502C9: an enzyme of major importance in human drug metabolism. Br J Clin Pharmacol 45:525\u2013538","journal-title":"Br J Clin Pharmacol"},{"key":"9347_CR10","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1021\/jm7009793","volume":"51","author":"MJ Sykes","year":"2008","unstructured":"Sykes MJ, McKinnon RA, Miners JO (2008) Prediction of metabolism by cytochrome P450 2C9: alignment and docking studies of a validated database of substrates. J Med Chem 51:780\u2013791","journal-title":"J Med Chem"},{"key":"9347_CR11","doi-asserted-by":"crossref","first-page":"35630","DOI":"10.1074\/jbc.M405427200","volume":"279","author":"MR Wester","year":"2004","unstructured":"Wester MR, Yano JK, Schoch GA, Yang C, Griffin KJ, Stout CD, Johnson EF (2004) The structure of human cytochrome P450 2C9 complexed with flurbiprofen at 2.0-A resolution. J Biol Chem 279:35630\u201335637","journal-title":"J Biol Chem"},{"key":"9347_CR12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10822-007-9137-8","volume":"9","author":"T Polg\u00e1r","year":"2007","unstructured":"Polg\u00e1r T, Menyh\u00e1rd DK, Keseru GM (2007) Effective virtual screening protocol for CYP2C9 ligands using a screening site constructed from flurbiprofen and S-warfarin pockets. J Comput Aided Mol Des 9:539\u2013548","journal-title":"J Comput Aided Mol Des"},{"key":"9347_CR13","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.bbagen.2006.09.013","volume":"1770","author":"M Otyepka","year":"2007","unstructured":"Otyepka M, Skopal\u00edk J, Anzenbacherov\u00e1 E, Anzenbacher P (2007) What common structural features and variations of mammalian P450\u00a0s are known to date? Biochim Biophys Acta 1770:376\u2013389","journal-title":"Biochim Biophys Acta"},{"key":"9347_CR14","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.bbagen.2008.06.001","volume":"1780","author":"Z Bik\u00e1di","year":"2008","unstructured":"Bik\u00e1di Z, Hazai E (2008) In silico description of differential enantioselectivity in methoxychlor O-demethylation by CYP2C enzymes. Biochim Biophys Acta 1780:1070\u20131079","journal-title":"Biochim Biophys Acta"},{"key":"9347_CR15","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1021\/jm000048n","volume":"43","author":"S Rao","year":"2000","unstructured":"Rao S, Aoyama R, Schrag M, Trager WF, Rettie A, Jones JP (2000) A refined 3-dimensional QSAR of cytochrome P450 2C9: computational predictions of drug interactions. J Med Chem 43:2789\u20132796","journal-title":"J Med Chem"},{"key":"9347_CR16","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1124\/mol.59.4.909","volume":"59","author":"L Afzelius","year":"2001","unstructured":"Afzelius L, Zamora I, Ridderstr\u00f6m M, Andersson TB, Karl\u00e9n A, Masimirembwa CM (2001) Competitive CYP2C9 inhibitors: enzyme inhibition studies, protein homology modeling, and three-dimensional quantitative structure-activity relationship analysis. Mol Pharmacol 59:909\u2013919","journal-title":"Mol Pharmacol"},{"key":"9347_CR17","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1021\/jm0110791","volume":"45","author":"MJ Groot de","year":"2002","unstructured":"de Groot MJ, Alex AA, Jones BC (2002) Development of a combined protein and pharmacophore model for cytochrome P450 2C9. J Med Chem 45:1983\u20131993","journal-title":"J Med Chem"},{"key":"9347_CR18","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1021\/jm021104i","volume":"46","author":"I Zamora","year":"2003","unstructured":"Zamora I, Afzelius L, Cruciani G (2003) Predicting drug metabolism: a site of metabolism prediction tool applied to the cytochrome P450 2C9. J Med Chem 46:2313\u20132324","journal-title":"J Med Chem"},{"key":"9347_CR19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1023\/A:1020881520931","volume":"5\u20136","author":"S Boyer","year":"2002","unstructured":"Boyer S, Zamora I (2002) New methods in predictive metabolism. J Comput Aided Mol Des 5\u20136:403\u2013413","journal-title":"J Comput Aided Mol Des"},{"key":"9347_CR20","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1021\/jm0613471","volume":"50","author":"RP Sheridan","year":"2007","unstructured":"Sheridan RP, Korzekwa KR, Torres RA, Walker MJ (2007) Empirical regioselectivity models for human cytochromes P450 3A4, 2D6, and 2C9. J Med Chem 50:3173\u20133184","journal-title":"J Med Chem"},{"key":"9347_CR21","doi-asserted-by":"crossref","first-page":"8000","DOI":"10.1021\/jm8011257","volume":"51","author":"CC Peng","year":"2008","unstructured":"Peng CC, Cape JL, Rushmore T, Crouch GJ, Jones JP (2008) Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues. J Med Chem 51:8000\u20138011","journal-title":"J Med Chem"},{"key":"9347_CR22","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1021\/jm050529c","volume":"48","author":"G Cruciani","year":"2005","unstructured":"Cruciani G, Carosati E, De Boeck B, Ethirajulu K, Mackie C, Howe T, Vianello R (2005) MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist. J Med Chem 48:6970\u20136979","journal-title":"J Med Chem"},{"key":"9347_CR23","unstructured":"ROCS Openeye Scientific Software: Sante Fe, NM, 2006"},{"key":"9347_CR24","unstructured":"FRED Openeye Scientific Software: Sante Fe, NM, 2005"},{"key":"9347_CR25","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1023\/A:1008158231558","volume":"14","author":"GM Verkivker","year":"2000","unstructured":"Verkivker GM, Bouzida D, Gehlaar DK, Rejto PA, Arthurs S, Colson AB, Freer ST, Larson V, Luty BA, Marrone T, Rose PW (2000) Deciphering common failures in molecular docking of ligand-protein complexes. J Comp-Aided Mol Des 14:731\u2013751","journal-title":"J Comp-Aided Mol Des"},{"key":"9347_CR26","doi-asserted-by":"crossref","DOI":"10.1007\/b139087","volume-title":"Cytochrome P450 structure, mechanism, and biochemistry","author":"PR Ortiz de Montellano","year":"2005","unstructured":"Ortiz de Montellano PR (2005) Cytochrome P450 structure, mechanism, and biochemistry. Kluwer Academic\/Plenum Publishers, New York"},{"key":"9347_CR27","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0969-2126(98)00109-9","volume":"6","author":"JA Peterson","year":"1998","unstructured":"Peterson JA, Graham SE (1998) A close family resemblance: the importance of structure in understanding cytochromes P450. Structure\u00a06:1079\u20131085","journal-title":"Structure"},{"key":"9347_CR28","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1021\/bi00366a049","volume":"25","author":"TL Poulos","year":"1986","unstructured":"Poulos TL, Finzel BC, Howard AJ (1986) Crystal structure of substrate-free Pseudomonas putida cytochrome P-450. Biochemistry 25:5314\u20135322","journal-title":"Biochemistry"},{"key":"9347_CR29","doi-asserted-by":"crossref","first-page":"16122","DOI":"10.1016\/S0021-9258(17)36209-9","volume":"260","author":"TL Poulos","year":"1985","unstructured":"Poulos TL, Finzel BC, Gunsalus IC, Wagner GC, Kraut J (1985) The 2.6-A crystal structure of Pseudomonas putida cytochrome P-450. J Biol Chem 260:16122\u201316130","journal-title":"J Biol Chem"},{"key":"9347_CR30","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1021\/ja00128a019","volume":"117","author":"H Li","year":"1995","unstructured":"Li H, Narasimhulu S, Havran LM, Winkler JD, Poulos TL (1995) Crystal structure of cytochrome P-450 complexe with its catalytic product, 5-Exo-Hydroxycamphor. J Am Chem Soc 117:6297\u20136299","journal-title":"J Am Chem Soc"},{"key":"9347_CR31","doi-asserted-by":"crossref","first-page":"7586","DOI":"10.1021\/bi00445a013","volume":"28","author":"R Raag","year":"1989","unstructured":"Raag R, Poulos TL (1989) Crystal structure of the carbon monoxide-substrate-cytochrome P-450CAM ternary complex. Biochemistry 28:7586\u20137592","journal-title":"Biochemistry"},{"key":"9347_CR32","unstructured":"CompuDrug International, Inc (2003) 115 Morgan Drive, Sedona, AZ 86351, USA"},{"key":"9347_CR33","unstructured":"Glide, version 5.0 (2008) Schr\u00f6dinger, LLC, New York"},{"key":"9347_CR34","unstructured":"National Center for Biotechnology Information http:\/\/www.ncbi.nlm.nih.gov\/sites\/entrez Accessed 2009 February"},{"key":"9347_CR35","unstructured":"ChemAxon http:\/\/www.chemaxon.com Accessed 2009 February"},{"key":"9347_CR36","unstructured":"CompuDrug http:\/\/www.compudrug.com Accessed 2009 February"},{"key":"9347_CR37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/abbi.1999.1468","volume":"372","author":"M He","year":"1999","unstructured":"He M, Korzekwa KR, Jones JP, Rettie AE, Trager WF (1999) Structural forms of phenprocoumon and warfarin that are metabolized at the active site of CYP2C9. Arch Biochem Biophys 372:16\u201328","journal-title":"Arch Biochem Biophys"},{"key":"9347_CR38","unstructured":"LigPrep, version 2.3 (2009) Schr\u00f6dinger, LLC, New York"},{"key":"9347_CR39","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1021\/ci700052x","volume":"47","author":"GB McGaughey","year":"2007","unstructured":"McGaughey GB, Sheridan RP, Bayly CI, Culberson JC, Kreatsoulas C, Lindsley S, Maiorov V, Truchon JF, Cornell WD (2007) Comparison of topological, shape, and docking methods in virtual screening. J Chem Inf Model 47:1504\u20131519","journal-title":"J Chem Inf Model"},{"key":"9347_CR40","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1021\/ci800293n","volume":"49","author":"KE Hevener","year":"2009","unstructured":"Hevener KE, Zhao W, Ball DM, Babaoglu K, Qi J, White SW, Lee RE (2009) Validation of molecular docking programs for virtual screening against Dihydropteroate synthase. J Chem Inf Model 49:444\u2013460","journal-title":"J Chem Inf Model"},{"key":"9347_CR41","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1021\/jm0302997","volume":"47","author":"M Kontoyianni","year":"2004","unstructured":"Kontoyianni M, McClellan LM, Sokol GS (2004) Evaluation of docking performance: comparative data on docking algorithms. J Med Chem 47:558\u2013565","journal-title":"J Med Chem"},{"key":"9347_CR42","doi-asserted-by":"crossref","first-page":"10808","DOI":"10.1021\/bi990463l","volume":"38","author":"H Lee","year":"1999","unstructured":"Lee H, Ortiz de Montellano PR, McDermott AE (1999) Deuterium magic angle spinning studies of substrates bound to cytochrome P450. Biochemistry 38:10808\u201310813","journal-title":"Biochemistry"},{"key":"9347_CR43","unstructured":"UNITY, Tripos Inc. 1699 South Hanley Road St. Louis, MO 63144-2319 USA"},{"key":"9347_CR44","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1124\/dmd.105.008631","volume":"6","author":"D Zhou","year":"2006","unstructured":"Zhou D, Afzelius L, Grimm SW, Andersson TB, Zauhar RJ, Zamora I (2006) Comparison of methods for the prediction of the metabolic sites for CYP3A4-mediated metabolic reactions. Drug Metab Dispos 6:976\u2013983","journal-title":"Drug Metab Dispos"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-010-9347-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-010-9347-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-010-9347-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T12:37:48Z","timestamp":1635165468000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-010-9347-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,2]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["9347"],"URL":"https:\/\/doi.org\/10.1007\/s10822-010-9347-3","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,2]]}}}